Search results
Showing: 10 of 1534
NHS Business Services Authority publishes its End of Year Report 2019-20
NHS Business Services Authority (NHSBSA) has been responding to a national call for support during the coronavirus pandemic, working in partnership to stand up over 20 additional services since March 2020.
Allison Newell, Deputy CEO and Executive…
Updated endorsement guidance for SSP products
Pharmacy contractors should note that endorsement requirements for products supplied in accordance with a Serious Shortage Protocol (SSP) have been updated, as per Clause 9E, Part II of the June 2021 Drug Tariff.
The update will affect all future…
Patient exemption checking: a guide for ophthalmic teams in England
From 1 September 2021, the temporary signature suspension has been lifted. Patients, or their representatives, will again be required to sign the reverse of NHS prescription, dental and eye care forms, or tokens for prescriptions presented at the…
Reimbursement prices for November 2021
This article has been published on behalf of the Department of Health and Social Care.
The Department of Health and Social Care and the National Assembly of Wales have re-determined that the reimbursement price for the month of November 2021 for…
GP and Pharmacy support: open days, webinars and newsletters
We hold regular webinars and open days for prescribing and dispensing contractors on topics ranging from endorsing and referred backs to batch submissions and switching.
Online sessions last approximately 60 minutes.
In-person open days take…
Update on recent changes to FP17Ws
If you’re a provider in Wales, you’ll know that changes to FP17Ws were introduced from 1 April 2022.
Summary of changes introduced from 1 April 2022
From 1 April 2022, the following changes were introduced on FP17Ws:
some data items were…
Clinical Data Set items and treatment band on FP17Ws
As you will be aware, we introduced new rules in April around the Clinical Data Set (CDS) items entered on a claim. As part of these rules, the CDS items reported need to match the treatment band claimed.
To ensure a smoother introduction of the…
Dental Assurance Framework (DAF) report
The purpose of the quarterly DAF report is to support a standardised approach to contract performance managementmm and to effectively make use of the extensive data currently available.
Indicators used are designed to be informative about overall…
2023-24 Mid-year review revision
Following publication of mid-year performance letters on 31 October 2023, we have been contacted by colleagues raising concerns about the accuracy of their data. We have investigated these concerns, and we are sorry to advise that we have identified…
Release of the new Oversupply dashboard
The Oversupply dashboard is now available in ePACT2.
Oversupply is when more medication is dispensed than is typically needed or wanted by the patient. This dashboard will support improvement initiatives, particularly around addressing…